Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable.
Marc Fisher, Gregory W Albers, Geoffrey A Donnan, Anthony J Furlan, James C Grotta, Chelsea S Kidwell, Ralph L Sacco, Lawrence R Wechsler, undefined Stroke Therapy Academic Industry Roundtable IV
Stroke | Published : 2005
BACKGROUND: Previous Stroke Therapy Academic Industry Roundtable (STAIR) meetings focused on preclinical evidence of drug efficacy and enhancing acute stroke trial design and performance. A fourth (STAIR-IV) was held to discuss relevant issues related to acute stroke drug development and regulatory approval. SUMMARY OF REVIEW: The STAIR-IV meeting had 3 main focus areas. The first topic was novel approaches to statistical design of acute stroke trials and appropriate outcome measures. The second focus was the need for better cooperation among participants in stroke therapy development that may be addressed through a national consortium of stroke trial centers in the United States and elsewhe..View full abstract